Skip to main content
OpenTrials
Completed

NCT Number: NCT06000150

Characteristics of Trachomatous Corneal Opacity in Fayoum University Hospital

The purpose of this study is to assess the characteristics of trachomatous corneal opacity in patients with signs of trachoma using Anterior segment Optic coherence tomography and Pentacam

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Corneal Opacity Corneal Diseases Eye Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Fayoum University

Al Fayyum, 63514, Egypt

About this study

After approval of the local institutional ethics committee and local institutional review board, patient presented to Fayoum University Hospital was examined for corneal opacity with signs of trachoma after a detailed informed consent was signed by eligible patients and investigated by Anterior Segment Optic coherence Tomography and Pentacam.

Descriptive statistics were presented in the form of mean and standard deviation for numerical variables while numbers and percentages are used for the categorical variables.

Paired samples t-test was used to study anterior segment Optic Coherence tomography and pentacam in evaluating corneal thickness. Bland-Altman plot was used to study the agreement between the two methods IBM SPSS version 28 for Windows software was used for the analysis and Stata 16 was used for the Bland-Altman plot. A p-value of < 0.05 was considered significant.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with corneal opacity accompanied by signs of trachoma

Exclusion criteria

  • corneal opacity due other causes
  • history of corneal surgery

Treatment and study plan

corneal topography

Diagnostic Test

AS-OCT,PENTACAM

Primary outcomes

  1. Corneal imaging

    Time frame: we will recruit patients who meer the inclusion criteria during the study period february-August 2022

    AS-OCT and PENTACAM in patients with trachomatous corneal opacity

Sponsors and collaborators

Lead sponsor

Omar Said

Other

Registry information

Acronym: Trachoma

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Aug 21, 2023
Registry last updated
Aug 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.